SUN PHARM INDS LTD FDA Approval ANDA 091552

ANDA 091552

SUN PHARM INDS LTD

FDA Drug Application

Application #091552

Application Sponsors

ANDA 091552SUN PHARM INDS LTD

Marketing Status

Prescription001

Application Products

001TABLET;ORALEQ 2.5MG BASE0NARATRIPTANNARATRIPTAN HYDROCHLORIDE

FDA Submissions

ORIG1AP2011-02-14
LABELING; LabelingSUPPL2AP2015-09-22STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null7

TE Codes

001PrescriptionAB

CDER Filings

SUN PHARM INDS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91552
            [companyName] => SUN PHARM INDS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"NARATRIPTAN","activeIngredients":"NARATRIPTAN HYDROCHLORIDE","strength":"EQ 2.5MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"NARATRIPTAN","submission":"NARATRIPTAN HYDROCHLORIDE","actionType":"EQ 2.5MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.